Covered recipient · General Payments record
ERIC ROBERT MONG
Allopathic & Osteopathic Physicians Neurological Surgery
General Payments · PY2020–2024
$9,365.99
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,525.93 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Aesculap, Inc. | $344.16 | 4 |
| DePuy Synthes Sales Inc. | $294.66 | 3 |
| Kuros Biosciences USA, Inc | $221.03 | 1 |
| Innovasis Inc | $203.77 | 2 |
| Novocure Inc. | $153.80 | 1 |
| Augmedics Inc. | $137.68 | 2 |
| Merck Sharp & Dohme Corporation | $73.37 | 1 |
| Stryker Corporation | $69.76 | 1 |
| ZIMVIE INC. | $27.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aesculap, Inc. | $92.37 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154288468 | CMS |
| Aesculap, Inc. | $109.16 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154288470 | CMS |
| Aesculap, Inc. | $4.14 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154288472 | CMS |
| Aesculap, Inc. | $138.49 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154288474 | CMS |
| Augmedics Inc. | $93.75 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140890216 | CMS |
| Augmedics Inc. | $43.93 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140892653 | CMS |
| DePuy Synthes Sales Inc. | $19.01 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077858123 | CMS |
| DePuy Synthes Sales Inc. | $128.55 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077858338 | CMS |
| DePuy Synthes Sales Inc. | $147.10 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077858212 | CMS |
| Innovasis Inc | $125.83 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139248767 | CMS |
| Innovasis Inc | $77.94 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139251464 | CMS |
| Kuros Biosciences USA, Inc | $221.03 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139158317 | CMS |
| Merck Sharp & Dohme LLC | $73.37 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141610808 | CMS |
| Novocure Inc. | $153.80 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123335225 | CMS |
| Stryker Corporation | $69.76 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119920888 | CMS |
| ZIMVIE INC. | $27.70 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142549041 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.